CHRAC1 anticorps (C-Term)
Aperçu rapide pour CHRAC1 anticorps (C-Term) (ABIN2619256)
Antigène
Voir toutes CHRAC1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Recognizes endogenous levels of CHRAC1 protein.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
KLH-conjugated synthetic peptide encompassing a sequence within the C-terminal region of human CHRAC1.
Type of Immunogen: Synthetic peptide
-
-
-
-
Indications d'application
- Approved: IHC, IHC-P (1:100 - 1:200), WB (1:500 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.3, 0.01 % sodium azide, 30 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Aliquot to avoid freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot to avoid freeze/thaw cycles.
-
-
- CHRAC1 (Chromatin Accessibility Complex 1 (CHRAC1))
-
Autre désignation
- CHRAC1
-
Sujet
-
Name/Gene ID: CHRAC1
Synonyms: CHRAC1, CHARC1, CHRAC-1, HuCHRAC15, CHARC15, CHRAC-15, CHRAC15, Histone-fold protein CHRAC15, YCL1 -
ID gène
- 54108
Antigène
-